A Retrospective Study of Newly-diagnosed PCNSL Treated With a Methotrexate (MTX) and Orelabrutinib-based Regimen

Conditions: Primary Central Nervous System Lymphoma Interventions: Drug: Orelabrutinib Sponsors: Huashan Hospital Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials